[Federal Register Volume 80, Number 96 (Tuesday, May 19, 2015)]
[Notices]
[Pages 28715-28716]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12017]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2015-0102]


Information Collection: Destinations of Released Patients 
Following Treatment with Iodine-131 and Estimation of Doses to Members 
of the Public at Locations other than Conventional Residences Receiving 
Such Patients

AGENCY: Nuclear Regulatory Commission.

ACTION: Proposed information collection: Request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public 
comment on this proposed collection of information of Office of 
Management and Budget (OMB) approval for a proposed collection of 
information. The information collection is entitled, ``Destinations of 
Released Patients Following Treatment with Iodine-131 and Estimation of 
Doses to Members of the Public at Locations other than Conventional 
Residences Receiving Such Patients.''

DATES: Submit comments by July 20, 2015. Comments received after this 
date will be considered if it is practical to do so, but the Commission 
is able to ensure consideration only for comments received on or before 
this date.

ADDRESSES: You may submit comments by any of the following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2015-0102. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: [email protected]. For technical questions, contact 
the individual listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     Mail comments to: Tremaine Donnell, Office of Information 
Services, Mail Stop: T-5 F53, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001.
    For additional direction on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, Office of 
Information Services, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001; telephone: 301-415-6258; email: 
[email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2015-0102 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2015-0102. A copy of 
the collection of information and related instructions may be obtained 
without charge by accessing Docket ID NRC-2015-0102 on this Web site.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. A 
copy of the collection of information and related instructions may be 
obtained without charge by accessing ADAMS Accession No.: ML15086A164. 
The supporting statement available in ADAMS under Accession No. 
ML15086A166.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting NRC's Clearance Officer, Tremaine Donnell, Office of 
Information Services, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001; telephone: 301-415-6258; email: 
[email protected].

B. Submitting Comments

    Please include Docket ID NRC-2015-0102 in the subject line of your 
comment submission, in order to ensure that the NRC is able to make 
your comment submission available to the public in this docket.
    The NRC cautions you not to include identifying or contact 
information in comment submissions that you do not want to be publicly 
disclosed in your comment submission. The NRC will post all comment 
submissions at http://www.regulations.gov as well as enter the comment 
submissions into ADAMS, and the NRC does not routinely edit comment 
submissions to remove identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment into ADAMS.

[[Page 28716]]

II. Background

    In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. 
Chapter 35), the NRC is requesting public comment on its intention to 
request the OMB's approval for the information collection summarized 
below.
    1. The title of the information collection: Destinations of 
Released Patients Following Treatment with Iodine-131 and Estimation of 
Doses to Members of the Public at Locations other than Conventional 
Residences Receiving Such Patients.
    2. OMB approval number: An OMB control number has not yet been 
assigned to this proposed information collection.
    3. Type of submission: New.
    4. The form number, if applicable: NA.
    5. How often the collection is required or requested: One-time.
    6. Who will be required or asked to respond: Institutions that 
treat thyroid cancer patients with I-131 and the thyroid cancer 
patients who have been treated.
    7. The estimated number of annual responses: 5,175 (175 for 
treating institutions and 5000 for individuals).
    8. The estimated number of annual respondents: 5,175.
    9. The estimated number of hours needed annually to comply with the 
information collection requirement or request: 1,675 (175 hours for 
treating institution and 1500 hours for individuals).
    10. Abstract: Although most patients return to their home after 
receiving diagnostic or therapeutic of Iodine-131, some patients 
released by the licensee may stay at another location (such as a hotel) 
for a few days. However, the extent of this practice is unclear. The 
same uncertainty exists regarding patients returning to nursing homes 
and other institutional settings. Therefore, one of the main objectives 
of this study is to obtain reliable statistical data that provides good 
estimates of the prevalence of these practices. The second objective is 
to determine, by measurements, the external and internal doses received 
by members of the general public at hotels, nursing homes, or other 
institutional settings that receive treated patients immediately after 
their release.

III. Specific Requests for Comments

    The NRC is seeking comments that address the following questions:
    1. Is the proposed collection of information necessary for the NRC 
to properly perform its functions? Does the information have practical 
utility?
    2. Is the estimate of the burden of the information collection 
accurate?
    3. Is there a way to enhance the quality, utility, and clarity of 
the information to be collected?
    4. How can the burden of the information collection on respondents 
be minimized, including the use of automated collection techniques or 
other forms of information technology?

    Dated at Rockville, Maryland, this 13th day of May 2015.

    For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information Services.
[FR Doc. 2015-12017 Filed 5-18-15; 8:45 am]
 BILLING CODE 7590-01-P